In an interview with PharmaShots, Glenn Mattes, President, CEO, and Director at TFF Pharmaceuticals share his views on the thin film freezing technology for the development of vaccines and therapeutics against multiple infectious diseases including IPA
Shots:
The company focuses on developing and commercializing innovative drug products based on its patented TFF technology platform including the development of vaccines and therapeutics against multiple infectious…
